About Index Trending news
Lists
Pricing
Mersana Therapeutics

Mersana Therapeutics

Mersana Therapeutics

Rewriting the rules for immunoconjugate therapies.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding
IPO
$75,000,000
Venture capital (Series C)
$33,000,000
Employees

Unknown size

Locations
HQ
$75,000,000 IPO
PE Hub

VC-backed Mersana Therapeutics debuts IPO

Stock markets Health
$33,000,000 Venture capital (Series C)
biospace , mersana

Booming Mersana Nabs Another 33 Million for a Total Take of 120 Million

Health Funding